Table 5: Correlations between depressive symptoms and SLE clinical assessments.

SLE subjects
()Pseudo 2AICcCoefficientOdds ratio (95% CI) value

Characteristics
Disease duration (years), mean ± SD17.81 ± 8.850.021467.950.0061.01 (1.00-1.02)0.211
BMI, mean ± SD24.51 ± 5.600.103461.590.0211.02 (1.01–1.03)0.003
Smoking, number (%)
 Yes13 (18)0.032467.14−0.1860.83 (0.65–1.05)0.133
Drinking, number (%)
 Yes7 (10)0.006469.030.1001.11 (0.82–1.45)0.489
Physical activity, number (%)
 Yes24 (33)0.054465.43−0.1960.82 (0.68–0.99)0.047
Laboratory
Sedimentation velocity, mean ± SD23.48 ± 20.960.355440.120.0031.00 (1.00-1.01)0.220
C-reactive protein, mean ± SD0.44 ± 0.570.191454.670.1201.13 (0.97–1.29)0.094
Leukocytes, mean ± SD6.73 ± 2.130.160457.26−0.0031.00 (0.96–1.04)0.884
Brain leukocytes, mean ± SD6.22 ± 2.201.00091.440.1211.13 (1.04–1.23)0.005
Lymphocytes, mean ± SD28.89 ± 8.090.160457.270.0011.00 (0.99–1.01)0.929
Brain lymphocytes, mean ± SD29.05 ± 6.771.00096.64−0.0220.98 (0.95–1.01)0.117
Anti-dsDNA, mean ± SD98.79 ± 111.010.829370.64< 0.0011.00 (1.00-1.00)0.990
Brain anti-dsDNA, mean ± SD635.54 ± 1504.141.00096.28< 0.0011.00 (1.00-1.00)0.081